Best Dividend Stocks
ABT is currently part of our Best Dividend Stocks screen, indicating it pays a high and sustainable dividend.
ABBOTT LABORATORIES (ABT) Stock Price & Overview
NYSE:ABT • US0028241000
Current stock price
96 USD
-0.81 (-0.84%)
Last:
The current stock price of ABT is 96 USD. Today ABT is down by -0.84%. In the past month the price decreased by -9.68%. In the past year, price decreased by -26.09%.
ABT Key Statistics
52-Week Range93.92 - 139.06
Current ABT stock price positioned within its 52-week range.
1-Month Range93.92 - 107.79
Current ABT stock price positioned within its 1-month range.
- Market Cap
- 166.816B
- P/E
- 18.43
- Fwd P/E
- 15.28
- EPS (TTM)
- 5.21
- Dividend Yield
- 2.60%
ABT Stock Performance
Today
-0.84%
1 Week
-3.48%
1 Month
-9.68%
3 Months
-20.49%
Longer-term
6 Months -24.68%
1 Year -26.09%
2 Years -8.64%
3 Years -12.37%
5 Years -19.38%
10 Years +148.87%
ABT Stock Chart
ABT Stock Screens
ABT currently appears in the following ChartMill screener lists.
Dividend Growth Stocks
ABT is part of our Dividend Growth Stocks screen, indicating it has a reliable dividend with grows strongly
52-Week Low Stocks
ABT occurs in the near 52-week low stock list, indicating it is a potential value opportunity.
Highest Analyst Upside Stocks
ABT is part of our highest analyst upside stock list, indicating analysts have a price target way above the current price.
ABT Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ABT. When comparing the yearly performance of all stocks, ABT is a bad performer in the overall market: 88.37% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
ABT Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to ABT. Both the health and profitability get an excellent rating, making ABT a very profitable company, without any liquidiy or solvency issues.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ABT Earnings
On April 16, 2026 ABT reported an EPS of 1.15 and a revenue of 11.16B. The company missed EPS expectations (-0.45% surprise) and beat revenue expectations (0.5% surprise).
Next Earnings DateJul 15, 2026
Last Earnings DateApr 16, 2026
PeriodQ1 / 2026
EPS Reported$1.15
Revenue Reported11.164B
EPS Surprise -0.45%
Revenue Surprise 0.50%
ABT Forecast & Estimates
35 analysts have analysed ABT and the average price target is 134.69 USD. This implies a price increase of 40.3% is expected in the next year compared to the current price of 96.
For the next year, analysts expect an EPS growth of 10.72% and a revenue growth 8.79% for ABT
Analysts
Analysts80.57
Price Target134.69 (40.3%)
EPS Next Y10.72%
Revenue Next Year8.79%
ABT Groups
Sector & Classification
ABT Financial Highlights
Over the last trailing twelve months ABT reported a non-GAAP Earnings per Share(EPS) of 5.21. The EPS increased by 9% compared to the year before.
Income Statements
Revenue(TTM)45.13B
Net Income(TTM)6.52B
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.72% | ||
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| Debt/Equity | 0.19 |
Chartmill High Growth Momentum
EPS Q2Q%5.5%
Sales Q2Q%7.78%
EPS 1Y (TTM)9%
Revenue 1Y (TTM)6.59%
ABT Ownership
Ownership
Inst Owners81.92%
Shares1.74B
Float1.73B
Ins Owners0.47%
Short Float %1.38%
Short Ratio2.17
ABT Latest News, Press Relases and Analysis
4 days ago - By: Chartmill
19 days ago - By: Chartmill
ABT Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 45.66 | 166.649B | ||
| SYK | STRYKER CORP | 22.39 | 131.485B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.65 | 95.457B | ||
| IDXX | IDEXX LABORATORIES INC | 39.26 | 46.798B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.14 | 46.694B | ||
| BDX | BECTON DICKINSON AND CO | 11.6 | 45.143B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.34 | 34.067B | ||
| RMD | RESMED INC | 18.37 | 33.233B | ||
| DXCM | DEXCOM INC | 25.41 | 24.623B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.21 | 18.347B | ||
| PODD | INSULET CORP | 31.04 | 14.11B | ||
| PEN | PENUMBRA INC | 64.76 | 13.059B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ABT
Company Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 115,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Company Info
IPO: 1937-03-01
ABBOTT LABORATORIES
100 Abbott Park Road, Abbot Park
ABBOTT PARK ILLINOIS 60064 US
CEO: Robert B. Ford
Employees: 115000
Phone: 12246676100
ABBOTT LABORATORIES / ABT FAQ
What does ABT do?
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 115,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
What is the current price of ABT stock?
The current stock price of ABT is 96 USD. The price decreased by -0.84% in the last trading session.
Does ABBOTT LABORATORIES pay dividends?
ABBOTT LABORATORIES (ABT) has a dividend yield of 2.6%. The yearly dividend amount is currently 2.37.
How is the ChartMill rating for ABBOTT LABORATORIES?
ABT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
Can you provide the sector and industry classification for ABBOTT LABORATORIES?
ABBOTT LABORATORIES (ABT) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the upcoming dividend date for ABBOTT LABORATORIES?
The next ex-dividend date for ABBOTT LABORATORIES (ABT) is April 15, 2026.
Would investing in ABBOTT LABORATORIES be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ABT.